• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 7, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Research spotlights early signs of disease using infrared light: New research

Bioengineer by Bioengineer
March 21, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

While more research is needed to confirm the findings published today in the FASEB Journal, the use of FITR could herald a fast and easy way to spot early signs of infection, cancer, and difficult to diagnose neurological conditions.

The research led by Professors Peter Lay and Georges Grau used Fourier transform infrared (FTIR) spectroscopy to detect and characterize the release of sub-micron sized microvesicles.

Produced from the cell membranes of mammals, microvesicles play a role in cell communication and carry a "cargo" of RNA, DNA, proteins, lipids and other biomolecules that they use to dramatically change the biochemistry of other cells.

Microvesicles are involved in normal physiology but are released into the bloodstream at higher levels during the acute and early development phase of many diseases. They are also potent vectors and mediators of disease, so detecting changes in their number and biochemistry could be helpful for spotting mechanisms of early diseases development.

The researchers used FTIR to monitor microvesicle-biomolecular changes in white blood cells, known as monocytes, they stimulated with a component of deadly bacteria called lipopolysaccharide, comparing the changes to those in healthy, uninfected white blood cells.

Lipopolysaccahride from various bacteria can reach the blood and cause septic shock, a life-threatening complication of sepsis where the body's infection-response can injure tissues and organs.

"We found a threefold increase in the number of microvesicles from white blood cells stimulated with lipopolysaccharide that points to a pathophysiological role for these microvesicles in bacterial infection and its subsequent immune response," said study co-author Georges Grau at the University of Sydney's Vascular Immunology Unit and Marie Bashir Institute for Infectious Diseases.

"We also saw clear biomolecular changes – more lipids and proteins – in microvesicles produced by white blood cells stimulated by lipopolysaccharides, compared to those produced by resting white blood cells."

The researchers also discovered that most of the "cargo" of RNA, DNA, lipids and proteins released by the white blood cells were contained within these microvesicles.

"This is very important since there is an enormous research effort looking at circulating RNA, DNA and proteins in blood as diagnostics of diseases and our results indicate that they are mostly carried in these microvesicles," said senior author, Professor Peter Lay at the University's School of Chemistry and Vibrational Spectroscopy Core Facility.

"In many respects, the microvesicles released under bacterial stimulation during an infectious episode are like viruses whereby the altered lipid content and increases and proteins appear designed to invade and change the biochemistry of target cells by releasing their DNA and RNA.

"This use of FTIR spectroscopy to analyse microvesicles provides a new way characterize the biomolecular differences in this model of septic shock-induced white blood cell-microvesicle and could easily be applied to other models of microvesicle release, notably in a range of inflammatory diseases."

###

This research is a project of the University of Sydney's AINST Health and Medicine Flagship Program. It aims to discover new aspects of human diseases and new pathways for drug targeting from the myriad of endogenous biological nanovesicles released by the immune system in response to both infectious and non-infectious diseases.

Media Contact

Dan Gaffney
[email protected]
61-481-004-782
@SydneyUni_Media

http://www.usyd.edu.au/

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Evaluating the CCCQ for Chinese Cancer Caregivers

October 7, 2025

Soft Bioelectronics with DNA Circuit Monitor Wounds

October 7, 2025

Financial Protection Strategies for Cancer Patients: A Review

October 7, 2025

Scientists Discover Breakthrough Method to Halt Fatal Infection

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    841 shares
    Share 336 Tweet 210
  • New Study Reveals the Science Behind Exercise and Weight Loss

    98 shares
    Share 39 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    94 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    76 shares
    Share 30 Tweet 19

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Evaluating the CCCQ for Chinese Cancer Caregivers

Soft Bioelectronics with DNA Circuit Monitor Wounds

Financial Protection Strategies for Cancer Patients: A Review

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.